Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 09:32 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
AVORO CAPITAL ADVISORS LLC | 3,105,000 4.500% |
-895,000 (-22.38%) |
Filing History |
| 2023-02-14 08:44 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
Deep Track Capital, LP | 0 0.000% |
-3,362,000 (Position Closed) |
Filing History |
| 2023-02-13 6:17 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 3,800,983 5.700% |
253,900 (+7.16%) |
Filing History |
| 2023-02-13 1:07 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,376,815 9.300% |
2,804,396 (+78.50%) |
Filing History |
| 2023-02-10 1:48 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 6,638,371 9.900% |
2,094,924 (+46.11%) |
Filing History |
| 2023-02-10 10:05 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 2,383,000 3.560% |
-1,130,756 (-32.18%) |
Filing History |
| 2023-02-09 11:25 am Purchase |
2022-12-30 | 13G | Kura Oncology, Inc. KURA |
The Vanguard Group | 3,405,169 5.090% |
3,405,169 (New Position) |
Filing History |
| 2023-02-03 12:15 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
STATE STREET CORP STT |
4,446,427 6.650% |
1,068,284 (+31.62%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
BLACKROCK INC BLK |
5,162,836 7.600% |
67,810 (+1.33%) |
Filing History |
| 2022-12-05 4:45 pm Purchase |
2022-11-23 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 3,547,083 5.300% |
2,301,171 (+184.70%) |
Filing History |
| 2022-03-10 09:48 am Sale |
2022-03-09 | 13G | Kura Oncology, Inc. KURA |
FMR CORP | 241,463 0.362% |
-5,340,737 (-95.67%) |
Filing History |
| 2022-02-11 4:55 pm Purchase |
2021-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,572,419 5.400% |
69,000 (+1.97%) |
Filing History |
| 2022-02-11 2:03 pm Purchase |
2021-12-31 | 13G | Kura Oncology, Inc. KURA |
STATE STREET CORP STT |
3,378,143 5.080% |
3,378,143 (New Position) |
Filing History |
| 2022-02-03 9:43 pm Purchase |
2022-01-28 | 13G | Kura Oncology, Inc. KURA |
Deep Track Capital, LP | 3,362,000 5.050% |
3,362,000 (New Position) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Kura Oncology, Inc. KURA |
BLACKROCK INC BLK |
5,095,026 7.700% |
163,070 (+3.31%) |
Filing History |
| 2022-01-31 4:39 pm Purchase |
2022-01-21 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 4,543,447 6.800% |
2,770,410 (+156.25%) |
Filing History |
| 2022-01-10 1:26 pm Sale |
2022-01-07 | 13G | Kura Oncology, Inc. KURA |
FMR CORP | 5,582,200 8.387% |
-3,533,840 (-38.77%) |
Filing History |
| 2021-12-09 4:31 pm Purchase |
2021-11-29 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,503,419 5.300% |
3,503,419 (New Position) |
Filing History |
| 2021-12-03 3:07 pm Purchase |
2021-11-29 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 3,513,756 5.280% |
3,513,756 (New Position) |
Filing History |
| 2021-02-16 12:00 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 1,773,037 2.700% |
-2,468,916 (-58.20%) |
Filing History |